JNJ - CIK 0000200406
The table below shows JOHNSON & JOHNSON's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $24.53B | $24.27B | $22.79B | $21.19B | $23.41B | $23.54B |
| Capital expenditure | $4.83B | $4.42B | $4.54B | $4.01B | $3.65B | $3.35B |
| Investing cash flow | -$23.59B | -$18.60B | $878.00M | -$12.37B | -$8.68B | -$20.82B |
| Dividends paid | - | - | - | - | - | - |
JOHNSON & JOHNSON reported operating cash flow of $24.53B for fiscal year 2025. That is up 1.1% from $24.27B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $18.77B (FY 2017) to $24.53B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | $5.95B | $2.43B | $5.05B | $6.04B | $3.46B | $3.22B |
| Financing cash flow | -$5.54B | -$3.13B | -$15.82B | -$8.87B | -$14.05B | -$6.12B |